Przebieg i wyniki leczenia chorych na rozlanego chloniaka (DLBCL) ?ol??dka


Author(s): Elżbieta StarosÅ?awska, Aneta DobrzyÅ?ska-Rutkowska, Anna Twardosz, Maria Luiza Kusz, Iwona Hus, Maria Mazurkiewicz

It is still under discussion what is the optimal treatment of primary gastric diffuse large Bcell lymphoma (PG-DLBCL). Currently, an antracyclins-based chemotherapy combined with rituximab is thought to facilitate complete remission without the need for a surgical intervention. The course and results of the treatment of patients suffering from primary gastric diffuse large B-cell lymphoma in the Centre of Oncology of Lubelska Land in the period 2003-2010 have been presented. 7 patients were enrolled in the study, with four of them subject to initial surgical treatment and six – to immunochemotherapy under the R-CHOP-21 regime. Only one subject included in the study underwent CHOP chemotherapy. In all patients complete remission (CR) was achieved and sustained from 79 to 3 months.


Share this article

Awards Nomination

Editors List

  • Prof. Elhadi Miskeen

    Obstetrics and Gynaecology Faculty of Medicine, University of Bisha, Saudi Arabia

  • Ahmed Hussien Alshewered

    University of Basrah College of Medicine, Iraq

  • Sudhakar Tummala

    Department of Electronics and Communication Engineering SRM University – AP, Andhra Pradesh




  • Alphonse Laya

    Supervisor of Biochemistry Lab and PhD. students of Faculty of Science, Department of Chemistry and Department of Chemis


  • Fava Maria Giovanna


Google Scholar citation report
Citations : 2495

Onkologia i Radioterapia received 2495 citations as per Google Scholar report

Onkologia i Radioterapia peer review process verified at publons
Indexed In
  • Scimago
  • MIAR
  • Euro Pub
  • Google Scholar
  • Medical Project Poland
  • Cancer Index
  • Gdansk University of Technology, Ministry Points 20